Benign essential blepharospasm.
Whitney
Christina M
CM
Movement Disorders Center, Department of Neurology, University Hospitals Health Systems, Cleveland, Ohio, USA.
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D001764:Blepharospasm / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D001905:Botulinum Toxins / Q000627:therapeutic use; D046690:Deep Brain Stimulation; D006801:Humans; D009121:Muscle Denervation
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins